Table 3

Independent determinants of the prevalence of current injecting and the incidence of injecting transitions, using 13 620 visits of 996 drug users in the Amsterdam Cohort Study

Current injecting
OR
Initiation
OR
Cessation
OR
Relapse
OR
Year3-151 1.170.573-150 0.710.803-150
Year3-150Year3-151 0.963-165 1.053-160
Female0.643-165
Non-West European ethnicity0.233-165 0.323-150 1.603-160
Non-Dutch nationality1.953-165
Age3-152 0.613-150 0.853-150
Duration of injecting3-152 NANA1.143-150
HIV positive1.403-160
Duration stopped injecting3-152 NANANA0.813-165
Current behaviours: 3-153
Non-injecting heroin use3-154
 <daily0.973.481.343-165
 daily0.803-160 7.133-160 1.683-165
Non-injecting cocaine use3-154
 <daily0.813-165
 daily0.91
Tranquiliser use3-154
 <daily1.333-165 2.441.403-150
 daily1.223-160 3.473-150 0.98
Prostitution1.633-165
Steady sexual partner
 none1111
 currently injecting1.563-165 3.353-150 0.703-160 1.17
 stopped injecting0.583-165 2.401.220.87
 never injected0.663-165 0.891.223-150 0.673-165
Daily methadone0.763-165
AIDS diagnosis1.803-160
Needles via exchange
 noneNANA1NA
 1–99%0.673-160
 100%0.503-165
Frequency injecting
 <dailyNANA1NA
 daily0.473-165
 >daily0.383-165
  • 3-150 , p<0.05;

  • 3-160 , p<0.01;

  • 3-165 , p<0.001; GEE was used for significance testing, using a logistic link function; calendar year was forced into the models; NA, not applicable.

  • 3-151 OR expressed per five year increase in calendar year.

  • 3-152 OR expressed per category of years (see methods).

  • 3-153 For injecting transitions, current behaviours were measured at the last cohort visit preceding the transition. For prevalence of current injecting, they were measured at the same visit as current injecting.

  • 3-154 Reference group is no use of drug.